Lily Cheung - 23 Jan 2024 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
Chief Human Resource Officer
Signature
/s/Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
23 Jan 2024
Net transactions value
$0
Form type
4
Filing time
24 Jan 2024, 16:57:05 UTC
Previous filing
23 Jan 2023
Next filing
22 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Award $0 +26,000 +3270% $0.000000 26,795 23 Jan 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (Right to Buy) Award $0 +52,000 $0.000000 52,000 23 Jan 2024 Common Stock 52,000 $17.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2 Includes 795 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
F3 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.